Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

BACKGROUND: Tumour relapse is recognized to be the prime fatal burden in patients affected by head and neck squamous cell carcinoma (HNSCC), but no discrete molecular trait has yet been identified to make reliable early predictions of tumour recurrence. Expression of cell surface proteoglycans (PGs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnedi, Anna, Rossi, Silvia, Bertani, Nicoletta, Gulli, Mariolina, Silini, Enrico Maria, Mucignat, Maria Teresa, Poli, Tito, Sesenna, Enrico, Lanfranco, Davide, Montebugnoli, Lucio, Leonardi, Elisa, Marchetti, Claudio, Cocchi, Renato, Ambrosini-Spaltro, Andrea, Foschini, Maria Pia, Perris, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429505/
https://www.ncbi.nlm.nih.gov/pubmed/25935541
http://dx.doi.org/10.1186/s12885-015-1336-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429505/
https://www.ncbi.nlm.nih.gov/pubmed/25935541
http://dx.doi.org/10.1186/s12885-015-1336-4

Ejemplares similares